Recall image placeholder

No image published for this recall

Aved products recall: no market authorization

Official notice

2 Apr 2026

Last checked

2 Apr 2026

Low riskHealth Canada
Watch Aved

An official Health Canada notice concerns Aved products recall: no market authorization. Products sold without market authorization (DIN) in Canada due to third-party branding. Published 2026-04-02.

What to do now

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

Recall number

81839

Official notice

2026-04-02

The hazard

Products sold without market authorization (DIN) in Canada due to third-party branding.

How to check if you're affected

Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.

Other

RA RA-81839

Recall Numbers

81839

Checked manually this time?

The app watches your VIN and alerts you automatically next time — no searching, no checking back.

Turn on automatic VIN checks

Affected products

Product 1

Product Name - Atropine Sulfate 0.01% Ophthalmic Solution, 5 mL, Lot Number - 11122025@5, 01052026@11

Product 2

Product Name - Atropine Sulfate 0.02% Ophthalmic Solution, 5 mL, Lot Number - 10162025@3, 12052025@5, 01272026@13

Product 3

Product Name - Atropine Sulfate 0.025% Ophthalmic Solution, 5 mL, Lot Number - 10162025@5, 12082025@12, 01272026@14, 02252026@5

Product 4

Product Name - Atropine Sulfate 0.05% Ophthalmic Solution, 5 mL, Lot Number - 10022025@3, 11202025@8, 01152026@6, 02042026@14

Product 5

Product Name - Fluorescein Na 0.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 5 mL, Lot Number - 11202025@5, 12082025@11, 12232025@2, 01212026@10

Product 6

Product Name - Insulin Regular (Human) 25 IU/mL Ophthalmic Solution, 10 mL, Lot Number - 10232025@3, 11142025@4, 12112025@3, 01222026@8

Product 7

Product Name - Mitomycin 0.04% Ophthalmic Solution (PF), 0.75 mL, Lot Number - 01192026@8

Product 8

Product Name - Moxifloxacin HCl 150 mcg/0.1 mL Ophthalmic Injection Solution, 0.75 mL, Lot Number - 01192026@8

Product 9

Product Name - Prednisolone Sodium Phosphate 1% / Moxifloxacin 0.5% / Bromfenac 0.075%, Lot Number - 12162026@11

Risk / hazard

Products sold without market authorization (DIN) in Canada due to third-party branding.

Where it was sold

The source does not list specific retailers. See the official notice for where affected vehicles were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada · Ontario

Company & contacts

Brand

Aved

Manufacturer

the recalling firm if you have any questions about the recall

Phone

Not provided

Brand: Aved. Contact: the recalling firm if you have any questions about the recall.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

Classification

Type III

App estimate

low

Recall details

Recall number

81839

Classification

Type III

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
Recall image placeholder

Nicotine pouch recall; no market authorization

Medium riskHealth Canada10 Jun 2026
CA
Recall image placeholder

Nitrous oxide chargers: sold for inhalation without market authorization (din)

High riskHealth Canada11 May 2026
CA
Recall image placeholder

Stay safe when buying health products online

Risk not stated by sourceHealth Canada7 May 2026
CA
Recall image placeholder

Nitrous oxide chargers: sold for inhalation without market authorization (din)

High riskHealth Canada15 Apr 2026
CA
Recall image placeholder

Nitrous oxide chargers: sold for inhalation without market authorization (din)

High riskHealth Canada14 Apr 2026
CA
Recall image placeholder

Nitrous oxide chargers: sold for inhalation without market authorization (din)

High riskHealth Canada19 Mar 2026
CA
Recall image placeholder

Nitrous oxide chargers: sold for inhalation without market authorization (din)

High riskHealth Canada12 Mar 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 2 Apr 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.